These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10380019)

  • 1. Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.
    Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Ceriani RL; Foon KA; Chatterjee SK
    Hybridoma; 1999 Apr; 18(2):193-202. PubMed ID: 10380019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.
    Chakraborty M; Mukerjee S; Foon KA; Köhler H; Ceriani RL; Bhattacharya-Chatterjee M
    Cancer Res; 1995 Apr; 55(7):1525-30. PubMed ID: 7533665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.
    Yang J; Kanter G; Voloshin A; Michel-Reydellet N; Velkeen H; Levy R; Swartz JR
    Biotechnol Bioeng; 2005 Mar; 89(5):503-11. PubMed ID: 15669088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
    Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
    Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice.
    Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF
    Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
    Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma.
    Tao MH; Levy R
    Nature; 1993 Apr; 362(6422):755-8. PubMed ID: 8469286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice.
    Cui H; Chang XH; Liu B; Feng J; Li Y; Ye X; Cao SJ; Fu TY; Yao Y; Li HQ; Qian HN
    Int J Gynecol Cancer; 2004; 14(2):234-41. PubMed ID: 15086722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The construction and expression of 6B11scFv anti-idiotypic antibody and human granulocyte-macrophage-colony stimulating factor in Escherichia coli].
    Yang F; Qian H; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):417-9. PubMed ID: 11360654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
    Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
    Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver disease.
    Saito H; Tada S; Ebinuma H; Atsukawa K; Masuda T; Inagaki Y; Tsuchimoto K; Morizane T; Ishii H
    Hepatology; 1996 Jun; 23(6):1498-506. PubMed ID: 8675170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.